Jay R. Campbell
Directeur/Membre du Conseil chez Update Pharma, Inc.
Postes actifs de Jay R. Campbell
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Update Pharma, Inc.
 Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jay R. Campbell
Anciens postes connus de Jay R. Campbell
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Corporate Officer/Principal | - | - |
| IMMUTEP LIMITED | Investor Relations Contact | 01/02/2017 | - |
Formation de Jay R. Campbell
| Bucknell University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Australie | 2 |
Opérationnelle
| Investor Relations Contact | 1 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Distribution Services |
- Bourse
- Insiders
- Jay R. Campbell
- Expérience
